Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Feeling abnormal? 181 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Feeling abnormal have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.7% of all adverse event reports for CANAGLIFLOZIN.

181
Reports of Feeling abnormal with CANAGLIFLOZIN
0.7%
of all CANAGLIFLOZIN reports
1
Deaths
27
Hospitalizations

How Dangerous Is Feeling abnormal From CANAGLIFLOZIN?

Of the 181 reports, 1 (0.6%) resulted in death, 27 (14.9%) required hospitalization, and 3 (1.7%) were considered life-threatening.

Is Feeling abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 181 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Feeling abnormal?

ADALIMUMAB (4,860) ETANERCEPT (4,533) PREGABALIN (4,451) SODIUM OXYBATE (3,018) DULOXETINE (2,875) TREPROSTINIL (2,704) TERIPARATIDE (2,673) LEVOTHYROXINE (2,671) SACUBITRIL\VALSARTAN (2,595) TOFACITINIB (2,533)

Which CANAGLIFLOZIN Alternatives Have Lower Feeling abnormal Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Feeling abnormal Reports All Drugs Causing Feeling abnormal CANAGLIFLOZIN Demographics